Nestlé opens two consumer healthcare factories in China

Nestlé has announced it is investing CHF 150 million (AU$201 million) in two new consumer healthcare factories in the China Medical City in Taizhou, Nestlé Health Science and Galderma.

Built on 13 hectares, the factories will meet the needs of consumers for Foods for Special Medical Purposes (FSMP) and skincare products.

Magdi Batato, executive vice president, head of operations for Nestlé S.A, said, “Nestlé is fully committed to continue to invest to support sustainable growth in China. By bringing the manufacturing capabilities of Nestlé Health Science and Nestlé Skin Health to China, we are in a stronger position to enhance Nestlé’s product offering and meet consumer expectations.”

Nestlé recognised that consumer health care has huge growth potential, and complements its core food and beverage business.

Rashid Qureshi, chairman and CEO of Nestlé Greater China, said the new factories “underscore Nestlé’s commitment to nutrition, health and wellness, which is fully in line with government’s priority to build a healthier population in China”.

The Chinese market is particularly lucrative, and the opening of two new factories follows Nestlé Health Science’s recent partnership with AliHealth to offer consumers the Boost range of science-based nutrition.

“The FSMP industry is expected to become the new blue ocean for China’s health industry,” said Liu Xuecong, secretary-general of the China Nutritional and Health Food Association. “Nestlé Taizhou factory is scientifically and technologically advanced and will undoubtedly play an important role in supporting the healthy development of China’s FSMP industry.”

Image credit: ©stock.adobe.com/au/ikostudio